Pinnacle Associates LTD Sage Therapeutics, Inc. Transaction History

Pinnacle Associates LTD

$6.21 Billion
Q2 2024

A detailed history of Pinnacle Associates LTD transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Pinnacle Associates LTD holds 293,251 shares of SAGE stock, worth $2.04 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

293,251

Previous 285,917 2.57%

Holding current value

$2.04 Million

Previous $5.36 Million 40.57%

% of portfolio

0.05%

Previous 0.09%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$10.58 - $17.9 $77,593 - $131,278	7,334 Added 2.57%	293,251 $3.18 Million
Q1 2024 Apr 26, 2024	BUY	$18.62 - $26.95 $2.18 Million - $3.16 Million	117,344 Added 69.61%	285,917 $5.36 Million
Q4 2023 Jan 19, 2024	SELL	$17.1 - $22.26 $127,292 - $165,703	-7,444 Reduced 4.23%	168,573 $3.65 Million
Q3 2023 Oct 23, 2023	SELL	$16.75 - $48.98 $100,014 - $292,459	-5,971 Reduced 3.28%	176,017 $3.62 Million
Q2 2023 Jul 26, 2023	SELL	$40.65 - $59.54 $203,128 - $297,521	-4,997 Reduced 2.67%	181,988 $8.56 Million
Q1 2023 May 04, 2023	BUY	$37.27 - $46.57 $566,653 - $708,050	15,204 Added 8.85%	186,985 $7.85 Million
Q4 2022 Jan 31, 2023	SELL	$32.2 - $43.61 $231,518 - $313,555	-7,190 Reduced 4.02%	171,781 $6.55 Million
Q4 2022 Jan 25, 2023	BUY	$32.2 - $43.61 $328,601 - $445,040	10,205 Added 6.05%	178,971 $0
Q3 2022 Oct 31, 2022	SELL	$32.28 - $43.27 $181,800 - $243,696	-5,632 Reduced 3.23%	168,766 $6.61 Million
Q2 2022 Aug 02, 2022	SELL	$27.52 - $37.99 $70,203 - $96,912	-2,551 Reduced 1.44%	174,398 $5.63 Million
Q1 2022 May 05, 2022	SELL	$30.71 - $45.71 $59,669 - $88,814	-1,943 Reduced 1.09%	176,949 $5.86 Million
Q4 2021 Feb 02, 2022	BUY	$37.06 - $47.11 $24,126 - $30,668	651 Added 0.37%	178,892 $7.61 Million
Q3 2021 Oct 19, 2021	BUY	$40.26 - $57.37 $4.04 Million - $5.75 Million	100,268 Added 128.59%	178,241 $7.9 Million
Q2 2021 Aug 02, 2021	BUY	$54.88 - $79.29 $53,123 - $76,752	968 Added 1.26%	77,973 $4.43 Million
Q1 2021 May 12, 2021	SELL	$70.65 - $96.76 $542,592 - $743,116	-7,680 Reduced 9.07%	77,005 $5.76 Million
Q4 2020 Jan 26, 2021	SELL	$58.41 - $89.06 $329,140 - $501,853	-5,635 Reduced 6.24%	84,685 $7.33 Million
Q3 2020 Oct 23, 2020	SELL	$41.13 - $62.45 $153,826 - $233,563	-3,740 Reduced 3.98%	90,320 $5.52 Million
Q2 2020 Aug 14, 2020	BUY	$25.95 - $43.15 $2.44 Million - $4.06 Million	94,060 New	94,060 $3.91 Million

Others Institutions Holding SAGE

# of Institutions

217

Shares Held

48.2M

Call Options Held

854K

Put Options Held

195K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $414M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Associates LTD with notifications on news.

Account

Pinnacle Associates LTD Sage Therapeutics, Inc. Transaction History